|
시장보고서
상품코드
1762405
세계의 대동맥 장골 폐색 질환 치료 시장, 규모, 점유율, 산업 분석 보고서 : 디바이스 유형별, 시술별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)Aorto-Iliac Occlusive Disease Treatment Market Size, Share, & Industry Analysis Report: By Device Type (Endovascular Devices and Surgical Devices), By Procedure, By End Use, and By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 대동맥 장골 폐색 질환 치료 시장 규모는 2034년까지 35억 6,000만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
대동맥 장골 폐색 질환 치료 시장은 일반적으로 죽상동맥경화증으로 인해 발생하는 대동맥과 장골동맥에서 발생하는 동맥폐쇄의 내과적 및 외과적 관리를 다루고 있습니다. 당뇨병, 고혈압, 비만과 같은 만성 질환 증가로 인해 혈관 내 치료와 개복 수술에 대한 임상적 수요가 증가하고 있습니다. 혈관 내 치료, 특히 혈관성형술과 스텐트 삽입술은 낮은 합병증 발생률, 짧은 입원 기간, 개선된 환자 예후로 인해 선호되는 치료 접근법이 되었습니다.
약물 용출 스텐트, 생체 흡수성 스캐폴드, 영상 유도 네비게이션 시스템 등 정확성과 장기적 유효성을 향상시키는 기기 기술의 발전이 시장 성장을 뒷받침하고 있습니다. 업계는 복잡한 병변과 다층폐색을 치료하기 위한 하이브리드 혈행재건술에 집중하고 있으며, 치료 최적화를 위한 새로운 길을 개척하고 있습니다. 또한 저침습적 치료가 대량으로 이루어지는 외래 혈관 치료 센터로의 이동이 증가하고 있습니다. 조기발견, 위험군 분류, 생활습관 개선 프로그램이 강조되면서 통합적 치료 모델의 중요성이 커지고 있습니다.
영상진단, 인공지능, 혈관 로봇공학의 융합은 치료의 패러다임을 서서히 바꾸고 있으며, 보다 개인화된 데이터 기반 치료의 길을 열어가고 있습니다. 임상시험과 시판 후 조사에 대한 투자는 기기의 안전성, 내구성, 성능에 대한 지표를 지속적으로 제공합니다. 치료받지 못하는 환자군의 차세대 치료 접근성을 확대하고 고위험군 환자의 치료 결과를 개선하기 위해 치료 알고리즘을 개선하는 데서 비즈니스 기회가 있습니다. 이 시장은 시술의 효율성, 장기 생존율, 환자의 삶의 질에 중점을 둔 보다 기술적으로 효과적이고 결과에 초점을 맞춘 생태계로 꾸준히 진화하고 있습니다.
대동맥 폐쇄성 질환 치료 시장 보고서 - 주요 내용
장치 유형별로는 혈관 내 치료 장치 분야가 2024년 가장 큰 점유율을 차지했으며, 이는 주로 대동맥-장골 폐쇄성 질환 관리에서 저침습적 수술에 대한 선호도가 높아진 데 따른 것으로 분석됩니다.
최종 사용자에 따라 2024년에는 병원 부문이 가장 큰 점유율을 차지했습니다. 이는 다학제 팀, 고급 영상 진단, 외과적 백업이 필요한 고위험 환자를 관리할 수 있는 능력에 힘입어 성장세를 보였습니다.
2024년 북미 대동맥 장골 폐색 질환 치료 시장은 첨단 혈관 내 치료법의 보급, 강력한 상환 제도, 조기 진단의 실천으로 인해 가장 큰 점유율을 차지할 것으로 예측됩니다.
아시아태평양 대동맥 장골 폐색 질환 치료 시장은 의료 접근성 향상, 의료 인프라 확대, 혈관 질환에 대한 인식 증가로 인해 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예측됩니다.
세계 주요 기업으로는 Abbott;&BD;:Bentley InnoMed;&Biotronik SE &Co KG;:Boston Scientific Corporation;&Cook;&Getinge AB;:iVascular;;;;. Medtronic;&Scitech Medical;&Terumo Corporation;&W. L. Gore &Associates, Inc. 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 대동맥 장골 폐색 질환 치료 시장 인사이트
- 시장 현황
- 대동맥 장골 폐색 질환 치료 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTEL 분석
- 대동맥 장골 폐색 질환 치료 시장 동향
- 밸류체인 분석
제5장 세계의 대동맥 장골 폐색 질환 치료 시장 : 디바이스 유형별
- 주요 조사 결과
- 서론
- 혈관내 기기
- 외과용 기기
제6장 세계의 대동맥 장골 폐색 질환 치료 시장 : 시술별
- 주요 조사 결과
- 서론
- 혈관내 수술
- 하이브리드 수술
- 개복 수술
제7장 세계의 대동맥 장골 폐색 질환 치료 시장 : 최종 용도별
- 주요 조사 결과
- 서론
- 병원
- 외래시설
- 기타
제8장 세계의 대동맥 장골 폐색 질환 치료 시장 : 지역별
- 주요 조사 결과
- 서론
- 대동맥 장골 폐색 질환 치료 시장 평가 : 지역별, 2020년-2034년
- 북미
- 북미 : 디바이스 유형별, 2020-2034년
- 북미 : 시술별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 디바이스 유형별, 2020-2034년
- 유럽 : 시술별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 디바이스 유형별, 2020년-2034년
- 아시아태평양 : 시술별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 디바이스 유형별, 2020년-2034년
- 중동 및 아프리카 : 시술별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 디바이스 유형별, 2020년-2034년
- 라틴아메리카 : 시술별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Abbott
- BD.
- Bentley InnoMed
- Biotronik SE & Co KG
- Boston Scientific Corporation
- Cook
- Getinge AB
- iVascular
- Medtronic
- Scitech Medical
- Terumo Corporation
- W. L. Gore & Associates, Inc.
- ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
The aorto-iliac occlusive disease treatment market size is expected to reach USD 3.56 billion by 2034, according to a new study by Polaris Market Research. The report "Aorto-Iliac Occlusive Disease Treatment Market Size, Share, & Industry Analysis Report: By Device Type (Endovascular Devices and Surgical Devices), By Procedure, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The aorto-iliac occlusive disease treatment market addresses the medical and surgical management of arterial blockages occurring in the aorta and iliac arteries, typically caused by atherosclerosis. The increasing prevalence of chronic conditions such as diabetes, hypertension, and obesity has intensified clinical demand for both endovascular and open surgical interventions. Endovascular procedures, particularly angioplasty and stenting, have become the preferred therapeutic approach due to their lower complication rates, reduced hospital stays, and improved patient outcomes.
Market growth is supported by advancements in device technologies, including drug-eluting stents, bioresorbable scaffolds, and image-guided navigation systems, which enhance precision and long-term efficacy. Industry players are focusing on hybrid revascularization techniques to treat complex lesions and multilevel occlusions, creating new avenues for treatment optimization. There is also a rising trend toward outpatient vascular care centers, where minimally invasive interventions are being performed in high volumes. Increasing emphasis on early detection, risk stratification, and lifestyle modification programs has elevated the importance of integrated care models.
The convergence of diagnostic imaging, artificial intelligence, and vascular robotics is gradually transforming the treatment paradigm, paving the way for more personalized, data-driven interventions. Investments in clinical trials and post-market surveillance studies continue to inform device safety, durability, and performance metrics. Opportunities lie in expanding access to next-generation therapies in underserved populations and refining treatment algorithms to improve outcomes in high-risk patients. The market is steadily evolving into a more technologically enabled, outcome-focused ecosystem that emphasizes procedural efficiency, long-term patency, and patient quality of life.
Aorto-Iliac Occlusive Disease Treatment Market Report Highlights
By device type, in 2024, the endovascular devices segment captured the largest share, primarily driven by the increasing preference for minimally invasive surgery in managing aorto-iliac occlusive disease.
Based on end use, in 2024, the hospitals segment accounted for the largest share, fueled by their capacity to manage high-risk cases requiring multidisciplinary teams, advanced imaging, and surgical backup.
In 2024, the North America aorto-iliac occlusive disease treatment market accounted for the largest share due to the widespread use of advanced endovascular procedures, strong reimbursement frameworks, and early diagnosis practices.
The Asia Pacific aorto-iliac occlusive disease treatment market is projected to register the highest CAGR during the forecast period due to rising healthcare access, expanding medical infrastructure, and increasing awareness of vascular conditions.
A few global key players include Abbott; BD.; Bentley InnoMed; Biotronik SE & Co KG; Boston Scientific Corporation; Cook; Getinge AB; iVascular; Medtronic; Scitech Medical; Terumo Corporation; W. L. Gore & Associates, Inc.; and ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Polaris Market Research has segmented the aorto-iliac occlusive disease treatment market on the basis of device type, procedure, end use, and region:
By Device Type Outlook (Revenue, USD Billion, 2020-2034)
Endovascular Devices
Balloon Angioplasty Devices
Atherectomy Systems
Stents
Surgical Devices
By Procedure Outlook (Revenue, USD Billion, 2020-2034)
Endovascular Procedures
Hybrid Procedures
Open Surgical Procedures
By End Use Outlook (Revenue, USD Billion, 2020-2034)
Hospitals
Outpatient Facilities
Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Aorto-Iliac Occlusive Disease Treatment Market Insights
- 4.1. Aorto-Iliac Occlusive Disease Treatment Market - Market Snapshot
- 4.2. Aorto-Iliac Occlusive Disease Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Peripheral Arterial Disease (PAD)
- 4.2.1.2. Growing Geriatric Population
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of Advanced Treatments
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Aorto-Iliac Occlusive Disease Treatment Market Trends
- 4.6. Value Chain Analysis
5. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 5.3. Endovascular Devices
- 5.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Endovascular Devices, by Region, 2020-2034 (USD Billion)
- 5.4. Surgical Devices
- 5.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Surgical Devices, by Region, 2020-2034 (USD Billion)
6. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 6.3. Endovascular Procedures
- 6.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Endovascular Procedures, by Region, 2020-2034 (USD Billion)
- 6.4. Hybrid Procedures
- 6.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Hybrid Procedures, by Region, 2020-2034 (USD Billion)
- 6.5. Open Surgical Procedures
- 6.5.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Open Surgical Procedures, by Region, 2020-2034 (USD Billion)
7. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 7.3. Hospitals
- 7.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Hospitals, by Region, 2020-2034 (USD Billion)
- 7.4. Outpatient Facilities
- 7.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Outpatient Facilities, by Region, 2020-2034 (USD Billion)
- 7.5. Others
- 7.5.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Others, by Region, 2020-2034 (USD Billion)
8. Global Aorto-Iliac Occlusive Disease Treatment Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Aorto-Iliac Occlusive Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Aorto-Iliac Occlusive Disease Treatment Market - North America
- 8.3.1. North America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.3.3. North America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. Aorto-Iliac Occlusive Disease Treatment Market - U.S.
- 8.3.4.1. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. Aorto-Iliac Occlusive Disease Treatment Market - Canada
- 8.3.5.1. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4. Aorto-Iliac Occlusive Disease Treatment Market - Europe
- 8.4.1. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.4.3. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. Aorto-Iliac Occlusive Disease Treatment Market - UK
- 8.4.4.1. UK: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. Aorto-Iliac Occlusive Disease Treatment Market - France
- 8.4.5.1. France: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.5.2. France: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.4.5.3. France: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. Aorto-Iliac Occlusive Disease Treatment Market - Germany
- 8.4.6.1. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. Aorto-Iliac Occlusive Disease Treatment Market - Italy
- 8.4.7.1. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. Aorto-Iliac Occlusive Disease Treatment Market - Spain
- 8.4.8.1. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. Aorto-Iliac Occlusive Disease Treatment Market - Netherlands
- 8.4.9.1. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. Aorto-Iliac Occlusive Disease Treatment Market - Russia
- 8.4.10.1. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5. Aorto-Iliac Occlusive Disease Treatment Market - Asia Pacific
- 8.5.1. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. Aorto-Iliac Occlusive Disease Treatment Market - China
- 8.5.4.1. China: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.4.2. China: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.5.4.3. China: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. Aorto-Iliac Occlusive Disease Treatment Market - India
- 8.5.5.1. India: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.5.2. India: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.5.5.3. India: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. Aorto-Iliac Occlusive Disease Treatment Market - Malaysia
- 8.5.6.1. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. Aorto-Iliac Occlusive Disease Treatment Market - Japan
- 8.5.7.1. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. Aorto-Iliac Occlusive Disease Treatment Market - Indonesia
- 8.5.8.1. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. Aorto-Iliac Occlusive Disease Treatment Market - South Korea
- 8.5.9.1. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. Aorto-Iliac Occlusive Disease Treatment Market - Australia
- 8.5.10.1. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.6. Aorto-Iliac Occlusive Disease Treatment Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. Aorto-Iliac Occlusive Disease Treatment Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. Aorto-Iliac Occlusive Disease Treatment Market - UAE
- 8.6.5.1. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. Aorto-Iliac Occlusive Disease Treatment Market - Israel
- 8.6.6.1. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. Aorto-Iliac Occlusive Disease Treatment Market - South Africa
- 8.6.7.1. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.7. Aorto-Iliac Occlusive Disease Treatment Market - Latin America
- 8.7.1. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. Aorto-Iliac Occlusive Disease Treatment Market - Mexico
- 8.7.4.1. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. Aorto-Iliac Occlusive Disease Treatment Market - Brazil
- 8.7.5.1. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. Aorto-Iliac Occlusive Disease Treatment Market - Argentina
- 8.7.6.1. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. BD.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Bentley InnoMed
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Biotronik SE & Co KG
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Boston Scientific Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Cook
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Getinge AB
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. iVascular
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Medtronic
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Scitech Medical
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Terumo Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. W. L. Gore & Associates, Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
